Czechia vs Estonia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Czechia
1.49
in 2026
Estonia
1.08
in 2026
Czechia rank
8th
Estonia rank
11th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Czechia
- Estonia
How they compare
Czechia currently reports 1.49 against 1.08 in Estonia, a difference of 0.41.
That makes Czechia's figure about 1.4 times Estonia's.
The two have swapped places 6 times across 27 shared years of data; in 2000 it was Czechia ahead.
Czechia ranks 8th and Estonia ranks 11th of 27 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.06 | 1.36 | 0.699 | Czechia |
| 2010s | 1.98 | 1.84 | 0.144 | Czechia |
| 2020s | 1.83 | 1.69 | 0.14 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Czechia or Estonia?
- Czechia, at 1.49 against 1.08 in Estonia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Czechia and Estonia?
- 0.41, with Czechia ahead.
- How many years of comparable data are there for Czechia and Estonia?
- 27 years are reported by both, from 2000 to 2026.
- How do Czechia and Estonia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Czechia ranks 8th and Estonia ranks 11th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.